{"id":"glucose-based-peritoneal-dialysate","safety":{"commonSideEffects":[{"rate":null,"effect":"Peritonitis"},{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Abdominal discomfort"},{"rate":null,"effect":"Catheter-related infections"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Peritoneal dialysate containing glucose creates an osmotic gradient across the peritoneal membrane, drawing excess water and small solute molecules from the bloodstream into the dialysate fluid. The glucose concentration in the solution determines the osmotic strength and ultrafiltration rate. This allows patients with kidney failure to perform peritoneal dialysis at home or in clinical settings without requiring hemodialysis machines.","oneSentence":"Glucose-based peritoneal dialysate facilitates removal of uremic waste products and excess fluid from the blood across the peritoneal membrane during peritoneal dialysis.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:33:02.661Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"End-stage renal disease requiring peritoneal dialysis"}]},"trialDetails":[{"nctId":"NCT07163936","phase":"NA","title":"Analysis of the Influence of Dialysis Fluid Composition on Vascular Calcification in Patients With Chronic Kidney Disease Undergoing Hemodialysis","status":"NOT_YET_RECRUITING","sponsor":"Hospital Clinic of Barcelona","startDate":"2025-09-03","conditions":"Vascular Calcification, Hemodialysis, Cardiovascular Disease (CKD)","enrollment":80},{"nctId":"NCT06983509","phase":"","title":"Registry of Pre-mixed Solutions in Critically Ill Patients on the Continuous Renal Replacement Therapy","status":"RECRUITING","sponsor":"Vantive Health LLC","startDate":"2024-09-23","conditions":"Renal Insufficiency","enrollment":220},{"nctId":"NCT06119373","phase":"NA","title":"Incremental PD With Single Icodextrin Exchange","status":"NOT_YET_RECRUITING","sponsor":"RenJi Hospital","startDate":"2023-12-01","conditions":"Peritoneal Dialysis Complication, Residual Kidney Function, Survival","enrollment":72},{"nctId":"NCT05195125","phase":"PHASE1","title":"Use of Direct Peritoneal Resuscitation in High-risk Liver Transplant Recipients","status":"UNKNOWN","sponsor":"University of Colorado, Denver","startDate":"2022-02-01","conditions":"End Stage Liver DIsease, Obesity, Acute Kidney Injury","enrollment":15},{"nctId":"NCT05780086","phase":"PHASE1","title":"Safety of and Tolerability to a Sodium-free Peritoneal Dialysis Solution","status":"UNKNOWN","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2023-02-03","conditions":"Chronic Kidney Diseases","enrollment":10},{"nctId":"NCT04001036","phase":"PHASE2","title":"Efficacy and Safety Assessments of a Peritoneal Dialysis Solution Containing Glucose, Xylitol, and L-Carnitine in CAPD","status":"TERMINATED","sponsor":"Iperboreal Pharma Srl","startDate":"2019-09-01","conditions":"End Stage Renal Disease","enrollment":11},{"nctId":"NCT05214872","phase":"","title":"The Impact of Selected Factors on the Cardiovascular System in Chronic Kidney Disease","status":"COMPLETED","sponsor":"Poznan University of Medical Sciences","startDate":"2016-03-25","conditions":"Atherosclerosis of Artery, Inflammation, Chronic Kidney Diseases","enrollment":252},{"nctId":"NCT03205553","phase":"PHASE1","title":"Direct Peritoneal Resuscitation in Gastroschisis","status":"TERMINATED","sponsor":"University of Arkansas","startDate":"2018-02-01","conditions":"Gastroschisis","enrollment":3},{"nctId":"NCT01228279","phase":"PHASE4","title":"Sympathetic Activity in Patients With End-stage Renal Disease on Peritoneal Dialysis","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2007-07","conditions":"End-stage Renal Disease (ESRD), Kidney Disease","enrollment":50},{"nctId":"NCT02708407","phase":"NA","title":"PD-HF: A Trial of Peritoneal Dialysis in Patients With Severe Heart Failure and Chronic Kidney Disease","status":"TERMINATED","sponsor":"University of Nottingham","startDate":"2016-01","conditions":"Heart Failure, Chronic Kidney Disease","enrollment":11},{"nctId":"NCT02212327","phase":"","title":"Testing Tissue Sodium Stores in CAPD Patients-Aims 1 & 2","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2014-08","conditions":"End Stage Renal Disease","enrollment":41},{"nctId":"NCT00851838","phase":"PHASE2","title":"L-Carnitine as an Osmo-metabolic Agent for Peritoneal Dialysis","status":"COMPLETED","sponsor":"Iperboreal Pharma Srl","startDate":"2009-06","conditions":"End-Stage Renal Disease","enrollment":5},{"nctId":"NCT02772146","phase":"NA","title":"A Clinical Study of the Safety and Efficacy of a Wearable Device (CLS UF) That Delivers Continuous Administration of Glucose to Recirculated Peritoneal Dialysis Fluid for the Purpose of Ultrafiltration in Patients With Congestive Heart Failure","status":"TERMINATED","sponsor":"Triomed AB","startDate":"2016-05-11","conditions":"Heart Failure, Cardio-Renal Syndrome","enrollment":2},{"nctId":"NCT01659554","phase":"PHASE2","title":"A Phase II Combined Modality Protocol of Debulking Surgery With HIPEC Followed by Intraperitoneal Chemotherapy for the Treatment of Recurrent Ovarian, Primary Peritoneal & Fallopian Tube Cancers","status":"TERMINATED","sponsor":"Columbia University","startDate":"2012-03","conditions":"Recurrent Ovarian Cancer, Fallopian Tube Cancer","enrollment":4},{"nctId":"NCT01119196","phase":"NA","title":"The Measurement of Insulin Resistance in Peritoneal Dialysis Patients","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2010-09","conditions":"End Stage Renal Disease","enrollment":10},{"nctId":"NCT01044446","phase":"PHASE4","title":"Effect of Icodextrin on the Treatment Outcome of Peritoneal Dialysis Patients During Acute Peritonitis","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2010-01","conditions":"Peritonitis","enrollment":56},{"nctId":"NCT01021878","phase":"PHASE4","title":"Study to Evaluate the Effects Icodextrin Versus Dianeal on Insulin Resistance in Nondiabetic Automated Peritoneal Dialysis Patients","status":"COMPLETED","sponsor":"Pontifícia Universidade Católica do Paraná","startDate":"2009-10","conditions":"Disorders Associated With Peritoneal Dialysis","enrollment":60},{"nctId":"NCT00966615","phase":"PHASE4","title":"The Effect of Neutral Peritoneal Dialysis (PD) Solution With Minimal Glucose-Degradation-Product (GDP) on Fluid Status and Body Composition","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2010-09","conditions":"Renal Failure, ESRD, Cardiovascular Disease","enrollment":68},{"nctId":"NCT01632046","phase":"PHASE4","title":"Administration of pH-Neutral Peritoneal Dialysis Solutions Containing Lactate or Bicarbonate in Children","status":"COMPLETED","sponsor":"Heidelberg University","startDate":"2004-03","conditions":"Chronic Renal Failure, Peritoneal Membrane Disorder","enrollment":42},{"nctId":"NCT00922701","phase":"PHASE2","title":"L-Carnitine in Peritoneal Dialysis","status":"COMPLETED","sponsor":"Iperboreal Pharma Srl","startDate":"2004-06","conditions":"End-Stage Renal Disease","enrollment":4}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"glucose-based peritoneal dialysate","genericName":"glucose-based peritoneal dialysate","companyName":"Chinese University of Hong Kong","companyId":"chinese-university-of-hong-kong","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Glucose-based peritoneal dialysate facilitates removal of uremic waste products and excess fluid from the blood across the peritoneal membrane during peritoneal dialysis. Used for End-stage renal disease requiring peritoneal dialysis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}